APO Research
Talk to an analyst

APO RESEARCH · REPORT

10% Dextrose Injection

10% Dextrose Injection is a packaged medical solution or multi-compartment preparation supplied for an identified parenteral-use specification.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Composition, compartment arrangement, container integrity and labelled use distinguish the product. Mixing compatibility, clinical selection and administration are separate product-specific requirements.

The commercial boundary

The selected edition describes a market scope. Product approvals, labelled use and clinical acceptance require their own evidence; neither report segmentation nor an illustrative image establishes medical suitability.

Which composition and container configuration define the preparation?

Composition, compartment arrangement, container integrity and labelled use distinguish the product. Mixing compatibility, clinical selection and administration are separate product-specific requirements.

Selected research

Industry Growth & Trends

Global 10% Dextrose Injection Industry Growth and Trends Forecast to 2032

2 January 202690 pages

Choose your research edition.

Industry Research10% Dextrose Injection Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal 10% Dextrose Injection Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal 10% Dextrose Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 10% Dextrose Injection Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal 10% Dextrose Injection Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global 10% Dextrose Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for 10% Dextrose Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for 10% Dextrose Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 10% Dextrose Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of 10% Dextrose Injection include Pfizer, Fresenius Kabi, Baxter, Schwitz Biotech, Otsuka Pharmaceutical, ICU Medical, Drugfield Pharmaceuticals Limited, B. Braun Medical Inc and Alfa Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global 10% Dextrose Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The 10% Dextrose Injection market size, estimates, and forecasts are presented in terms of sales volume (K L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global 10% Dextrose Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to 10% Dextrose Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global 10% Dextrose Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

10% Dextrose Injection Market by Company

Pfizer

Fresenius Kabi

Baxter

Schwitz Biotech

Otsuka Pharmaceutical

ICU Medical

Drugfield Pharmaceuticals Limited

B. Braun Medical Inc

Alfa Laboratories

10% Dextrose Injection Segment by Type

1000 mL

250 mL

500 mL

10% Dextrose Injection Segment by Application

Trophotherapy

Sports

First-Aid Treatment

Others

10% Dextrose Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 10% Dextrose Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 10% Dextrose Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 10% Dextrose Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of 10% Dextrose Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of 10% Dextrose Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1000 mL Table 2. Major Company of 250 mL Table 3. Major Company of 500 mL Table 4. Global 10% Dextrose Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global 10% Dextrose Injection Sales by Type (2021-2026) & (K L) Table 6. Global 10% Dextrose Injection Sales Market Share in Volume by Type (2021-2026) Table 7. Global 10% Dextrose Injection Sales by Type (2021-2026) & (US$ Million) Table 8. Global 10% Dextrose Injection Sales Market Share in Value by Type (2021-2026) Table 9. Global 10% Dextrose Injection Price by Type (2021-2026) & (US$/L) Table 10. Global 10% Dextrose Injection Sales by Type (2027-2032) & (K L) Table 11. Global 10% Dextrose Injection Sales Market Share in Volume by Type (2027-2032) Table 12. Global 10% Dextrose Injection Sales by Type (2027-2032) & (US$ Million) Table 13. Global 10% Dextrose Injection Sales Market Share in Value by Type (2027-2032) Table 14. Global 10% Dextrose Injection Price by Type (2027-2032) & (US$/L) Table 15. North America 10% Dextrose Injection Sales by Type (2021-2026) & (K L) Table 16. North America 10% Dextrose Injection Sales by Type (2021-2026) & (US$ Million) Table 17. Europe 10% Dextrose Injection Sales by Type (2021-2026) & (K L) Table 18. Europe 10% Dextrose Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific 10% Dextrose Injection Sales by Type (2021-2026) & (K L) Table 20. Asia-Pacific 10% Dextrose Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America 10% Dextrose Injection Sales by Type (2021-2026) & (K L) Table 22. Latin America 10% Dextrose Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa 10% Dextrose Injection Sales by Type (2021-2026) & (K L) Table 24. Middle East and Africa 10% Dextrose Injection Sales by Type (2021-2026) & (US$ Million) Table 25. 10% Dextrose Injection Industry Trends Table 26. 10% Dextrose Injection Industry Drivers Table 27. 10% Dextrose Injection Industry Opportunities and Challenges Table 28. 10% Dextrose Injection Industry Restraints Table 29. Global 10% Dextrose Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global 10% Dextrose Injection Revenue Market Share by Company (2021-2026) Table 31. Global 10% Dextrose Injection Sales by Company (2021-2026) & (K L) Table 32. Global 10% Dextrose Injection Sales Share by Company (2021-2026) Table 33. Global 10% Dextrose Injection Market Price by Company (2021-2026) & (US$/L) Table 34. Global 10% Dextrose Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global 10% Dextrose Injection Major Company Production Sites and Headquarters Table 36. Global 10% Dextrose Injection Company, Product Type & Application Table 37. Global 10% Dextrose Injection Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global 10% Dextrose Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global 10% Dextrose Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global 10% Dextrose Injection Sales by Region (2021-2026) & (K L) Table 42. Global 10% Dextrose Injection Sales Market Share in Volume by Region (2021-2026) Table 43. Global 10% Dextrose Injection Sales by Region (2021-2026) & (US$ Million) Table 44. Global 10% Dextrose Injection Sales Market Share in Value by Region (2021-2026) Table 45. Global 10% Dextrose Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 46. Global 10% Dextrose Injection Sales by Region (2027-2032) & (K L) Table 47. Global 10% Dextrose Injection Sales Market Share in Volume by Region (2027-2032) Table 48. Global 10% Dextrose Injection Sales by Region (2027-2032) & (US$ Million) Table 49. Global 10% Dextrose Injection Sales Market Share in Value by Region (2027-2032) Table 50. Global 10% Dextrose Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2027-2032) Table 51. Global 10% Dextrose Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global 10% Dextrose Injection Sales by Application (2021-2026) & (K L) Table 53. Global 10% Dextrose Injection Sales Market Share in Volume by Application (2021-2026) Table 54. Global 10% Dextrose Injection Sales by Application (2021-2026) & (US$ Million) Table 55. Global 10% Dextrose Injection Sales Market Share in Value by Application (2021-2026) Table 56. Global 10% Dextrose Injection Price by Application (2021-2026) & (US$/L) Table 57. Global 10% Dextrose Injection Sales by Application (2027-2032) & (K L) Table 58. Global 10% Dextrose Injection Sales Market Share in Volume by Application (2027-2032) Table 59. Global 10% Dextrose Injection Sales by Application (2027-2032) & (US$ Million) Table 60. Global 10% Dextrose Injection Sales Market Share in Value by Application (2027-2032) Table 61. Global 10% Dextrose Injection Price by Application (2027-2032) & (US$/L) Table 62. North America 10% Dextrose Injection Sales by Application (2021-2026) & (K L) Table 63. North America 10% Dextrose Injection Sales by Application (2021-2026) & (US$ Million) Table 64. Europe 10% Dextrose Injection Sales by Application (2021-2026) & (K L) Table 65. Europe 10% Dextrose Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific 10% Dextrose Injection Sales by Application (2021-2026) & (K L) Table 67. Asia-Pacific 10% Dextrose Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America 10% Dextrose Injection Sales by Application (2021-2026) & (K L) Table 69. Latin America 10% Dextrose Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa 10% Dextrose Injection Sales by Application (2021-2026) & (K L) Table 71. Middle East and Africa 10% Dextrose Injection Sales by Application (2021-2026) & (US$ Million) Table 72. Pfizer Company Information Table 73. Pfizer Business Overview Table 74. Pfizer 10% Dextrose Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 75. Pfizer 10% Dextrose Injection Product Portfolio Table 76. Pfizer Recent Development Table 77. Fresenius Kabi Company Information Table 78. Fresenius Kabi Business Overview Table 79. Fresenius Kabi 10% Dextrose Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 80. Fresenius Kabi 10% Dextrose Injection Product Portfolio Table 81. Fresenius Kabi Recent Development Table 82. Baxter Company Information Table 83. Baxter Business Overview Table 84. Baxter 10% Dextrose Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 85. Baxter 10% Dextrose Injection Product Portfolio Table 86. Baxter Recent Development Table 87. Schwitz Biotech Company Information Table 88. Schwitz Biotech Business Overview Table 89. Schwitz Biotech 10% Dextrose Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 90. Schwitz Biotech 10% Dextrose Injection Product Portfolio Table 91. Schwitz Biotech Recent Development Table 92. Otsuka Pharmaceutical Company Information Table 93. Otsuka Pharmaceutical Business Overview Table 94. Otsuka Pharmaceutical 10% Dextrose Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 95. Otsuka Pharmaceutical 10% Dextrose Injection Product Portfolio Table 96. Otsuka Pharmaceutical Recent Development Table 97. ICU Medical Company Information Table 98. ICU Medical Business Overview Table 99. ICU Medical 10% Dextrose Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 100. ICU Medical 10% Dextrose Injection Product Portfolio Table 101. ICU Medical Recent Development Table 102. Drugfield Pharmaceuticals Limited Company Information Table 103. Drugfield Pharmaceuticals Limited Business Overview Table 104. Drugfield Pharmaceuticals Limited 10% Dextrose Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 105. Drugfield Pharmaceuticals Limited 10% Dextrose Injection Product Portfolio Table 106. Drugfield Pharmaceuticals Limited Recent Development Table 107. B. Braun Medical Inc Company Information Table 108. B. Braun Medical Inc Business Overview Table 109. B. Braun Medical Inc 10% Dextrose Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 110. B. Braun Medical Inc 10% Dextrose Injection Product Portfolio Table 111. B. Braun Medical Inc Recent Development Table 112. Alfa Laboratories Company Information Table 113. Alfa Laboratories Business Overview Table 114. Alfa Laboratories 10% Dextrose Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 115. Alfa Laboratories 10% Dextrose Injection Product Portfolio Table 116. Alfa Laboratories Recent Development Table 117. North America 10% Dextrose Injection Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 118. North America 10% Dextrose Injection Sales by Country (2021-2026) & (K L) Table 119. North America 10% Dextrose Injection Sales Market Share by Country (2021-2026) Table 120. North America 10% Dextrose Injection Sales Forecast by Country (2027-2032) & (K L) Table 121. North America 10% Dextrose Injection Sales Market Share Forecast by Country (2027-2032) Table 122. North America 10% Dextrose Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America 10% Dextrose Injection Market Size by Country (2021-2026) & (US$ Million) Table 124. North America 10% Dextrose Injection Market Share by Country (2021-2026) Table 125. North America 10% Dextrose Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America 10% Dextrose Injection Market Share Forecast by Country (2027-2032) Table 127. Europe 10% Dextrose Injection Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 128. Europe 10% Dextrose Injection Sales by Country (2021-2026) & (K L) Table 129. Europe 10% Dextrose Injection Sales Market Share by Country (2021-2026) Table 130. Europe 10% Dextrose Injection Sales Forecast by Country (2027-2032) & (K L) Table 131. Europe 10% Dextrose Injection Sales Market Share Forecast by Country (2027-2032) Table 132. Europe 10% Dextrose Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe 10% Dextrose Injection Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe 10% Dextrose Injection Market Share by Country (2021-2026) Table 135. Europe 10% Dextrose Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe 10% Dextrose Injection Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific 10% Dextrose Injection Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific 10% Dextrose Injection Sales by Country (2021-2026) & (K L) Table 139. Asia-Pacific 10% Dextrose Injection Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific 10% Dextrose Injection Sales Forecast by Country (2027-2032) & (K L) Table 141. Asia-Pacific 10% Dextrose Injection Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific 10% Dextrose Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific 10% Dextrose Injection Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific 10% Dextrose Injection Market Share by Country (2021-2026) Table 145. Asia-Pacific 10% Dextrose Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific 10% Dextrose Injection Market Share Forecast by Country (2027-2032) Table 147. Latin America 10% Dextrose Injection Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 148. Latin America 10% Dextrose Injection Sales by Country (2021-2026) & (K L) Table 149. Latin America 10% Dextrose Injection Sales Market Share by Country (2021-2026) Table 150. Latin America 10% Dextrose Injection Sales Forecast by Country (2027-2032) & (K L) Table 151. Latin America 10% Dextrose Injection Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America 10% Dextrose Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America 10% Dextrose Injection Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America 10% Dextrose Injection Market Share by Country (2021-2026) Table 155. Latin America 10% Dextrose Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America 10% Dextrose Injection Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa 10% Dextrose Injection Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa 10% Dextrose Injection Sales by Country (2021-2026) & (K L) Table 159. Middle East and Africa 10% Dextrose Injection Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa 10% Dextrose Injection Sales Forecast by Country (2027-2032) & (K L) Table 161. Middle East and Africa 10% Dextrose Injection Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa 10% Dextrose Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa 10% Dextrose Injection Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa 10% Dextrose Injection Market Share by Country (2021-2026) Table 165. Middle East and Africa 10% Dextrose Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa 10% Dextrose Injection Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. 10% Dextrose Injection Distributors List Table 170. 10% Dextrose Injection Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. 10% Dextrose Injection Image Figure 2. Global 10% Dextrose Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 10% Dextrose Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global 10% Dextrose Injection Sales (2021-2032) & (K L) Figure 5. 1000 mL Image Figure 6. Global 1000 mL Sales YoY Growth (2021-2032) & (K L) Figure 7. 250 mL Image Figure 8. Global 250 mL Sales YoY Growth (2021-2032) & (K L) Figure 9. 500 mL Image Figure 10. Global 500 mL Sales YoY Growth (2021-2032) & (K L) Figure 11. Global 10% Dextrose Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global 10% Dextrose Injection Market Share by Type 2025 VS 2032 Figure 13. North America 10% Dextrose Injection Sales Market Share in Volume by Type in 2025 Figure 14. North America 10% Dextrose Injection Sales Market Share in Value by Type in 2025 Figure 15. Europe 10% Dextrose Injection Sales Market Share in Volume by Type in 2025 Figure 16. Europe 10% Dextrose Injection Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific 10% Dextrose Injection Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific 10% Dextrose Injection Sales Market Share in Value by Type in 2025 Figure 19. Latin America 10% Dextrose Injection Sales Market Share in Volume by Type in 2025 Figure 20. Latin America 10% Dextrose Injection Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa 10% Dextrose Injection Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa 10% Dextrose Injection Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 10% Dextrose Injection Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Trophotherapy Image Figure 26. Global Trophotherapy Sales YoY Growth (2021-2032) & (K L) Figure 27. Sports Image Figure 28. Global Sports Sales YoY Growth (2021-2032) & (K L) Figure 29. First-Aid Treatment Image Figure 30. Global First-Aid Treatment Sales YoY Growth (2021-2032) & (K L) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K L) Figure 33. Global 10% Dextrose Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global 10% Dextrose Injection Market Share by Application 2025 VS 2032 Figure 35. North America 10% Dextrose Injection Sales Market Share in Volume by Application in 2025 Figure 36. North America 10% Dextrose Injection Sales Market Share in Value by Application in 2025 Figure 37. Europe 10% Dextrose Injection Sales Market Share in Volume by Application in 2025 Figure 38. Europe 10% Dextrose Injection Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific 10% Dextrose Injection Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific 10% Dextrose Injection Sales Market Share in Value by Application in 2025 Figure 41. Latin America 10% Dextrose Injection Sales Market Share in Volume by Application in 2025 Figure 42. Latin America 10% Dextrose Injection Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa 10% Dextrose Injection Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa 10% Dextrose Injection Sales Market Share in Value by Application in 2025 Figure 45. North America 10% Dextrose Injection Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 46. North America 10% Dextrose Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America 10% Dextrose Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America 10% Dextrose Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe 10% Dextrose Injection Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 50. Europe 10% Dextrose Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe 10% Dextrose Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe 10% Dextrose Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific 10% Dextrose Injection Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 54. Asia-Pacific 10% Dextrose Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific 10% Dextrose Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific 10% Dextrose Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America 10% Dextrose Injection Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 58. Latin America 10% Dextrose Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America 10% Dextrose Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America 10% Dextrose Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa 10% Dextrose Injection Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 62. Middle East and Africa 10% Dextrose Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa 10% Dextrose Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa 10% Dextrose Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. 10% Dextrose Injection Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. 10% Dextrose Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 1000 mL
  • 250 mL
  • 500 mL
Applications
  • Trophotherapy
  • Sports
  • First-Aid Treatment
  • Others
Companies covered
  • Pfizer
  • Fresenius Kabi
  • Baxter
  • Schwitz Biotech
  • Otsuka Pharmaceutical
  • ICU Medical
  • Drugfield Pharmaceuticals Limited
  • B. Braun Medical Inc
  • Alfa Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global 10% Dextrose Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global 10% Dextrose Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 10% Dextrose Injection Market by Type
  6. 1.3.1 1000 mL
  7. 1.3.2 250 mL
  8. 1.3.3 500 mL
  9. 1.4 Global 10% Dextrose Injection Market Size by Type
  10. 1.4.1 Global 10% Dextrose Injection Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global 10% Dextrose Injection Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global 10% Dextrose Injection Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America 10% Dextrose Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe 10% Dextrose Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific 10% Dextrose Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America 10% Dextrose Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa 10% Dextrose Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 10% Dextrose Injection Industry Trends
  2. 2.2 10% Dextrose Injection Industry Drivers
  3. 2.3 10% Dextrose Injection Industry Opportunities and Challenges
  4. 2.4 10% Dextrose Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by 10% Dextrose Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by 10% Dextrose Injection Sales (2021-2026)
  3. 3.3 Global Top Players by 10% Dextrose Injection Price (2021-2026)
  4. 3.4 Global 10% Dextrose Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global 10% Dextrose Injection Major Company Production Sites & Headquarters
  6. 3.6 Global 10% Dextrose Injection Company, Product Type & Application
  7. 3.7 Global 10% Dextrose Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global 10% Dextrose Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 10% Dextrose Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 10% Dextrose Injection Tier 1, Tier 2, and Tier 3
4 10% Dextrose Injection Regional Status and Outlook
  1. 4.1 Global 10% Dextrose Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global 10% Dextrose Injection Historic Market Size by Region
  3. 4.2.1 Global 10% Dextrose Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global 10% Dextrose Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global 10% Dextrose Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global 10% Dextrose Injection Forecasted Market Size by Region
  7. 4.3.1 Global 10% Dextrose Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global 10% Dextrose Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global 10% Dextrose Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 10% Dextrose Injection by Application
  1. 5.1 10% Dextrose Injection Market by Application
  2. 5.1.1 Trophotherapy
  3. 5.1.2 Sports
  4. 5.1.3 First-Aid Treatment
  5. 5.1.4 Others
  6. 5.2 Global 10% Dextrose Injection Market Size by Application
  7. 5.2.1 Global 10% Dextrose Injection Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global 10% Dextrose Injection Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global 10% Dextrose Injection Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America 10% Dextrose Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe 10% Dextrose Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific 10% Dextrose Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America 10% Dextrose Injection Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa 10% Dextrose Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer 10% Dextrose Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer 10% Dextrose Injection Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 Fresenius Kabi
  8. 6.2.1 Fresenius Kabi Company Information
  9. 6.2.2 Fresenius Kabi Business Overview
  10. 6.2.3 Fresenius Kabi 10% Dextrose Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Fresenius Kabi 10% Dextrose Injection Product Portfolio
  12. 6.2.5 Fresenius Kabi Recent Developments
  13. 6.3 Baxter
  14. 6.3.1 Baxter Company Information
  15. 6.3.2 Baxter Business Overview
  16. 6.3.3 Baxter 10% Dextrose Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Baxter 10% Dextrose Injection Product Portfolio
  18. 6.3.5 Baxter Recent Developments
  19. 6.4 Schwitz Biotech
  20. 6.4.1 Schwitz Biotech Company Information
  21. 6.4.2 Schwitz Biotech Business Overview
  22. 6.4.3 Schwitz Biotech 10% Dextrose Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Schwitz Biotech 10% Dextrose Injection Product Portfolio
  24. 6.4.5 Schwitz Biotech Recent Developments
  25. 6.5 Otsuka Pharmaceutical
  26. 6.5.1 Otsuka Pharmaceutical Company Information
  27. 6.5.2 Otsuka Pharmaceutical Business Overview
  28. 6.5.3 Otsuka Pharmaceutical 10% Dextrose Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Otsuka Pharmaceutical 10% Dextrose Injection Product Portfolio
  30. 6.5.5 Otsuka Pharmaceutical Recent Developments
  31. 6.6 ICU Medical
  32. 6.6.1 ICU Medical Company Information
  33. 6.6.2 ICU Medical Business Overview
  34. 6.6.3 ICU Medical 10% Dextrose Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 ICU Medical 10% Dextrose Injection Product Portfolio
  36. 6.6.5 ICU Medical Recent Developments
  37. 6.7 Drugfield Pharmaceuticals Limited
  38. 6.7.1 Drugfield Pharmaceuticals Limited Company Information
  39. 6.7.2 Drugfield Pharmaceuticals Limited Business Overview
  40. 6.7.3 Drugfield Pharmaceuticals Limited 10% Dextrose Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Drugfield Pharmaceuticals Limited 10% Dextrose Injection Product Portfolio
  42. 6.7.5 Drugfield Pharmaceuticals Limited Recent Developments
  43. 6.8 B. Braun Medical Inc
  44. 6.8.1 B. Braun Medical Inc Company Information
  45. 6.8.2 B. Braun Medical Inc Business Overview
  46. 6.8.3 B. Braun Medical Inc 10% Dextrose Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 B. Braun Medical Inc 10% Dextrose Injection Product Portfolio
  48. 6.8.5 B. Braun Medical Inc Recent Developments
  49. 6.9 Alfa Laboratories
  50. 6.9.1 Alfa Laboratories Company Information
  51. 6.9.2 Alfa Laboratories Business Overview
  52. 6.9.3 Alfa Laboratories 10% Dextrose Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Alfa Laboratories 10% Dextrose Injection Product Portfolio
  54. 6.9.5 Alfa Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America 10% Dextrose Injection Sales by Country
  2. 7.1.1 North America 10% Dextrose Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America 10% Dextrose Injection Sales by Country (2021-2026)
  4. 7.1.3 North America 10% Dextrose Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America 10% Dextrose Injection Market Size by Country
  6. 7.2.1 North America 10% Dextrose Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America 10% Dextrose Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America 10% Dextrose Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe 10% Dextrose Injection Sales by Country
  2. 8.1.1 Europe 10% Dextrose Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe 10% Dextrose Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe 10% Dextrose Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe 10% Dextrose Injection Market Size by Country
  6. 8.2.1 Europe 10% Dextrose Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe 10% Dextrose Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe 10% Dextrose Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific 10% Dextrose Injection Sales by Country
  2. 9.1.1 Asia-Pacific 10% Dextrose Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific 10% Dextrose Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific 10% Dextrose Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific 10% Dextrose Injection Market Size by Country
  6. 9.2.1 Asia-Pacific 10% Dextrose Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific 10% Dextrose Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific 10% Dextrose Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America 10% Dextrose Injection Sales by Country
  2. 10.1.1 South America 10% Dextrose Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America 10% Dextrose Injection Sales by Country (2021-2026)
  4. 10.1.3 South America 10% Dextrose Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America 10% Dextrose Injection Market Size by Country
  6. 10.2.1 South America 10% Dextrose Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America 10% Dextrose Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America 10% Dextrose Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa 10% Dextrose Injection Sales by Country
  2. 11.1.1 Middle East and Africa 10% Dextrose Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa 10% Dextrose Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa 10% Dextrose Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa 10% Dextrose Injection Market Size by Country
  6. 11.2.1 Middle East and Africa 10% Dextrose Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa 10% Dextrose Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa 10% Dextrose Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 10% Dextrose Injection Value Chain Analysis
  2. 12.1.1 10% Dextrose Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 10% Dextrose Injection Production Mode & Process
  7. 12.2 10% Dextrose Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 10% Dextrose Injection Distributors
  10. 12.2.3 10% Dextrose Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst